Alterity Therapeutics (ASX:ATH) has FDA clarity, but Phase 3 funding now tests the rally business-news-today.com/alte… $ATH #AlterityTherapeutics #ATH434 #MultipleSystemAtrophy #BiotechStocks #ASX #FDA #Neurology #ASXstocks #ATH

facebook.com/share/p/1D53xDd… MSA affects thousands of people and families yet remains largely unknown. Great to see @ACurrentAffair9 helping raise awareness tonight. #MSA #MultipleSystemAtrophy

pharmadevicenews.com/why-fda… #AlterityTherapeutics #ATH434 #MultipleSystemAtrophy #FDA #ClinicalTrials #Neurology #Biotech

We’re thrilled to share our first-ever CURE-MSA Grant recipients! By uniting top #MSA Centers of Excellence, these collaborative projects aim to break down silos and accelerate a cure for #multiplesystematrophy. 🔬🧬 Read more: missionmsa.org/mission-msa-l… #research #raredisease

What’s cooking on the ASX? 👇 @AlterityT coverage via @australian & @StockheadAU Morning Feed after ATH announced FDA alignment on the key elements of its pivotal Phase 3 program for ATH434 in #MultipleSystemAtrophy stockhead.com.au/news/mornin… #MSA $ATH $ATHE

Alterity Therapeutics Secures FDA Green Light for ATH434 Phase 3 Trial in Multiple System Atrophy middle.news/s/2971fe6a-047d #ASX $ATH #Biotechnology #ClinicalTrials #RegulatoryApproval #NeurodegenerativeDiseases #MultipleSystemAtrophy

We want to thank RARE Revolution for giving us the opportunity to take over their socials today, to help spread awareness of what MSA is and the devastating affect it has on people lives. If you would like to learn more and support our mission you can follow us on social media at: @MSAtrust on Twitter/X @msatrust on Instagram @Multiple System Atrophy Trust on Facebook @msatrust.bsky.social on BlueSky Multiple System Atrophy Trust on LinkedIn #RARERevolution #Multiplesystematrophy #MSA #MSATrust @msatrust

@AlterityT Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy alteritytx.com/announcements… #Biomarker #MultipleSystemAtrophy #MSA #Neurodegeneration #biotech #clinicaltrials $ATH $ATHE

Phenoconversion in #PureAutonomicFailure is associated with risk for progression to #MultipleSystemAtrophy, #ParkinsonDisease, or #LewyBodyDementia. 🎧 Learn more in this podcast episode: ja.ma/4nmUWVS

This morning's update - Alterity Therapeutics to Deliver Presentations at Multiple Medical Conferences in May 2026 alteritytx.com/announcements… @AlterityT #MultipleSystemAtrophy #MSA #Neurodegeneration #biotech #clinicaltrials $ATH $ATHE

Thanks to all who joined today's virtual KOL event. Reminder that you can access the replay here: lifescievents.com/event/f91g… #MultipleSystemAtrophy #MSA #Neurodegeneration #biotech #clinicaltrials $ATH $ATHE

Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy @AlterityT #MultipleSystemAtrophy #MSA #Neurodegeneration #biotech #clinicaltrials $ATH $ATHE alteritytx.com/announcements…

Here's @AlterityT CEO Dr. David Stamler on the new analysis of ATH434 Phase 2 Trial data presented as a #LateBreaking science session of the American Academy of Neurology #AAN2026 #MultipleSystemAtrophy #MSA #Neurodegeneration $ATH $ATHE Full release here: alteritytx.com/announcements…

@AlterityT Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology #MultipleSystemAtrophy #MSA #Neurodegeneration #biotech #clinicaltrials $ATH $ATHE alteritytx.com/announcements…

Mark your calendars - Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy alteritytx.com/announcements… #MultipleSystemAtrophy #MSA #Neurodegeneration #biotech #clinicaltrials $ATH $ATHE

Thanks @wholesaleinvest for featuring @AlterityT- See the interview here discussing #MultipleSystemAtrophy #MSA #Neurodegeneration #biotech $ATH $ATHE youtube.com/watch?v=VNyABTk9…

ICYMI - Our announcement last week: @AlterityT Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program - with a write up here smallcaps.com.au/article/alt… from @SmallCapsASX #MultipleSystemAtrophy #MSA #Neurodegeneration #biotech #clinicaltrials $ATH $ATHE

#MSAAwarenessMonth is coming to an end. We want to thank everyone who participated and engaged. At @AlterityT we're dedicated to creating an alternate future for people living with neurodegenerative diseases. #MSAMonth #MultipleSystemAtrophy #MSA #Neurodegeneration #biotech

Together with the @MSAtrust we’ve launched an online course for all #healthcareprofessionals who work in #neurology or with neurological patients and would like to learn more about #multiplesystematrophy (MSA) management and care: ➡️ eu1.hubs.ly/H0sYqcK0 #MSAawarenessmonth

Throughout #MSAAwarenessMonth, we're highlighting those in the #MSACommunity - Check out Combat MSA! Their single purpose: to spark awareness, fuel life‑changing research, & stand shoulder to shoulder with everyone living with #MSA #MultipleSystemAtrophy combatmsa.org.au/